197 related articles for article (PubMed ID: 27260206)
21. Suppression of Canine Dendritic Cell Activation/Maturation and Inflammatory Cytokine Release by Mesenchymal Stem Cells Occurs Through Multiple Distinct Biochemical Pathways.
Wheat WH; Chow L; Kurihara JN; Regan DP; Coy JW; Webb TL; Dow SW
Stem Cells Dev; 2017 Feb; 26(4):249-262. PubMed ID: 27842458
[TBL] [Abstract][Full Text] [Related]
22. Comparative analysis of the immunomodulatory capacities of human bone marrow- and adipose tissue-derived mesenchymal stromal cells from the same donor.
Valencia J; Blanco B; Yáñez R; Vázquez M; Herrero Sánchez C; Fernández-García M; Rodríguez Serrano C; Pescador D; Blanco JF; Hernando-Rodríguez M; Sánchez-Guijo F; Lamana ML; Segovia JC; Vicente Á; Del Cañizo C; Zapata AG
Cytotherapy; 2016 Oct; 18(10):1297-311. PubMed ID: 27637760
[TBL] [Abstract][Full Text] [Related]
23. Effect of Mesenchymal Stromal Cells on T Cells in a Septic Context: Immunosuppression or Immunostimulation?
Le Burel S; Thepenier C; Boutin L; Lataillade JJ; Peltzer J
Stem Cells Dev; 2017 Oct; 26(20):1477-1489. PubMed ID: 28747098
[TBL] [Abstract][Full Text] [Related]
24. Adenosinergic Immunosuppression by Human Mesenchymal Stromal Cells Requires Co-Operation with T cells.
Kerkelä E; Laitinen A; Räbinä J; Valkonen S; Takatalo M; Larjo A; Veijola J; Lampinen M; Siljander P; Lehenkari P; Alfthan K; Laitinen S
Stem Cells; 2016 Mar; 34(3):781-90. PubMed ID: 26731338
[TBL] [Abstract][Full Text] [Related]
25. Comparative Analyses of Immunosuppressive Characteristics of Bone-Marrow, Wharton's Jelly, and Adipose Tissue-Derived Human Mesenchymal Stem Cells.
Karaöz E; Çetinalp Demircan P; Erman G; Güngörürler E; Eker Sarıboyacı A
Turk J Haematol; 2017 Aug; 34(3):213-225. PubMed ID: 27610554
[TBL] [Abstract][Full Text] [Related]
26. Xenotransplantation of interferon-gamma-pretreated clumps of a human mesenchymal stem cell/extracellular matrix complex induces mouse calvarial bone regeneration.
Takeshita K; Motoike S; Kajiya M; Komatsu N; Takewaki M; Ouhara K; Iwata T; Takeda K; Mizuno N; Fujita T; Kurihara H
Stem Cell Res Ther; 2017 Apr; 8(1):101. PubMed ID: 28446226
[TBL] [Abstract][Full Text] [Related]
27. Mesenchymal stromal cells derived from cervical cancer produce high amounts of adenosine to suppress cytotoxic T lymphocyte functions.
de Lourdes Mora-García M; García-Rocha R; Morales-Ramírez O; Montesinos JJ; Weiss-Steider B; Hernández-Montes J; Ávila-Ibarra LR; Don-López CA; Velasco-Velázquez MA; Gutiérrez-Serrano V; Monroy-García A
J Transl Med; 2016 Oct; 14(1):302. PubMed ID: 27782859
[TBL] [Abstract][Full Text] [Related]
28. The suppressive effect of mesenchymal stromal cells on T cell proliferation is conserved in old age.
Landgraf K; Brunauer R; Lepperdinger G; Grubeck-Loebenstein B
Transpl Immunol; 2011 Sep; 25(2-3):167-72. PubMed ID: 21726642
[TBL] [Abstract][Full Text] [Related]
29. Immunosuppressive capabilities of mesenchymal stromal cells are maintained under hypoxic growth conditions and after gamma irradiation.
Nold P; Hackstein H; Riedlinger T; Kasper C; Neumann A; Mernberger M; Fölsch C; Schmitt J; Fuchs-Winkelmann S; Barckhausen C; Killer M; Neubauer A; Brendel C
Cytotherapy; 2015 Feb; 17(2):152-62. PubMed ID: 25453724
[TBL] [Abstract][Full Text] [Related]
30. Stem cells isolated from the human stromal limbus possess immunosuppressant properties.
Garfias Y; Nieves-Hernandez J; Garcia-Mejia M; Estrada-Reyes C; Jimenez-Martinez MC
Mol Vis; 2012; 18():2087-95. PubMed ID: 22876135
[TBL] [Abstract][Full Text] [Related]
31. TLR ligands stimulation protects MSC from NK killing.
Giuliani M; Bennaceur-Griscelli A; Nanbakhsh A; Oudrhiri N; Chouaib S; Azzarone B; Durrbach A; Lataillade JJ
Stem Cells; 2014 Jan; 32(1):290-300. PubMed ID: 24123639
[TBL] [Abstract][Full Text] [Related]
32. Interleukin-17A-Induced Human Mesenchymal Stem Cells Are Superior Modulators of Immunological Function.
Sivanathan KN; Rojas-Canales DM; Hope CM; Krishnan R; Carroll RP; Gronthos S; Grey ST; Coates PT
Stem Cells; 2015 Sep; 33(9):2850-63. PubMed ID: 26037953
[TBL] [Abstract][Full Text] [Related]
33. Mesenchymal Stem Cells Derived from Human Bone Marrow and Adipose Tissue Maintain Their Immunosuppressive Properties After Chondrogenic Differentiation: Role of HLA-G.
Du WJ; Reppel L; Leger L; Schenowitz C; Huselstein C; Bensoussan D; Carosella ED; Han ZC; Rouas-Freiss N
Stem Cells Dev; 2016 Oct; 25(19):1454-69. PubMed ID: 27465875
[TBL] [Abstract][Full Text] [Related]
34. Immunomodulatory effects of bone marrow versus adipose tissue-derived mesenchymal stromal cells on NK cells: implications in the transplantation setting.
Blanco B; Herrero-Sánchez MD; Rodríguez-Serrano C; García-Martínez ML; Blanco JF; Muntión S; García-Arranz M; Sánchez-Guijo F; Del Cañizo C
Eur J Haematol; 2016 Dec; 97(6):528-537. PubMed ID: 27118602
[TBL] [Abstract][Full Text] [Related]
35. Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation.
Tse WT; Pendleton JD; Beyer WM; Egalka MC; Guinan EC
Transplantation; 2003 Feb; 75(3):389-97. PubMed ID: 12589164
[TBL] [Abstract][Full Text] [Related]
36. Identification of IL-1β and LPS as optimal activators of monolayer and alginate-encapsulated mesenchymal stromal cell immunomodulation using design of experiments and statistical methods.
Gray A; Maguire T; Schloss R; Yarmush ML
Biotechnol Prog; 2015; 31(4):1058-70. PubMed ID: 25958832
[TBL] [Abstract][Full Text] [Related]
37. Graft-Versus-Host Disease Amelioration by Human Bone Marrow Mesenchymal Stromal/Stem Cell-Derived Extracellular Vesicles Is Associated with Peripheral Preservation of Naive T Cell Populations.
Fujii S; Miura Y; Fujishiro A; Shindo T; Shimazu Y; Hirai H; Tahara H; Takaori-Kondo A; Ichinohe T; Maekawa T
Stem Cells; 2018 Mar; 36(3):434-445. PubMed ID: 29239062
[TBL] [Abstract][Full Text] [Related]
38. Inflammatory stimuli differentially modulate the transcription of paracrine signaling molecules of equine bone marrow multipotent mesenchymal stromal cells.
Vézina Audette R; Lavoie-Lamoureux A; Lavoie JP; Laverty S
Osteoarthritis Cartilage; 2013 Aug; 21(8):1116-24. PubMed ID: 23685224
[TBL] [Abstract][Full Text] [Related]
39. Characterization and functionality of the CD200-CD200R system during mesenchymal stromal cell interactions with T-lymphocytes.
Najar M; Raicevic G; Jebbawi F; De Bruyn C; Meuleman N; Bron D; Toungouz M; Lagneaux L
Immunol Lett; 2012 Aug; 146(1-2):50-6. PubMed ID: 22575528
[TBL] [Abstract][Full Text] [Related]
40. The immunomodulatory function of equine MSCs is enhanced by priming through an inflammatory microenvironment or TLR3 ligand.
Cassano JM; Schnabel LV; Goodale MB; Fortier LA
Vet Immunol Immunopathol; 2018 Jan; 195():33-39. PubMed ID: 29249315
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
